INTERNATIONAL PATENT: WUXI BIOLOGICS (SHANGHAI) CO., LTD., WUXI BIOLOGICS IRELAND LIMITED FILES APPLICATION FOR "CARS AND CAR-NK CELLS TARGETING BOTH BCMA AND GPRC5D AND USE THEREOF IN TREATING MULTIPLE MYELOMA"

GENEVA, June 2 -- WUXI BIOLOGICS (SHANGHAI) CO., LTD. (No. 299 Fute Zhong RoadPudong New Area, Shanghai 200131), WUXI BIOLOGICS IRELAND LIMITED (Mullagharlin, Dundalk, Co LouthA91 X56F) filed a patent application (PCT/CN2024/133844) for "CARS AND CAR-NK CELLS TARGETING BOTH BCMA AND GPRC5D AND USE THEREOF IN TREATING MULTIPLE MYELOMA" on Nov 22, 2024. With publication no. WO/2025/108429, the details related to the patent application was published on May 30, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): WANG, Hong (No. 299 Fute Zhong RoadPudong New Area, Shanghai 200131), ZHAO, Jiaojiao (No...